|
CDK14 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.95380000014944E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.07829999995701E-06 |
| Normal-vs-Stage2 |
1.048020E-02 |
| Normal-vs-Stage3 |
5.361800E-04 |
| Normal-vs-Stage4 |
1.214310E-04 |
| Stage1-vs-Stage2 |
5.656800E-01 |
| Stage1-vs-Stage3 |
4.210600E-01 |
| Stage1-vs-Stage4 |
8.694600E-01 |
| Stage2-vs-Stage3 |
9.807000E-01 |
| Stage2-vs-Stage4 |
5.547600E-01 |
| Stage3-vs-Stage4 |
5.036000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.64160000004632E-06 |
| Normal-vs-AfricanAmerican |
1.124380E-02 |
| Normal-vs-Asian |
1.92515999999365E-05 |
| Caucasian-vs-AfricanAmerican |
7.338800E-01 |
| Caucasian-vs-Asian |
3.026400E-01 |
| AfricanAmerican-vs-Asian |
3.040600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.1965999958139E-08 |
| Normal-vs-Female |
1.50067999999948E-05 |
| Male-vs-Female |
1.583740E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.27850000003682E-06 |
| Normal-vs-Age(41-60Yrs) |
2.01429999999725E-05 |
| Normal-vs-Age(61-80Yrs) |
2.44529999999799E-05 |
| Normal-vs-Age(81-100Yrs) |
3.180900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.792000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.536400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.694800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.077600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.879200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.812600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.555400E-01 |
| Classical-VS-Follicular |
3.804500E-04 |
| Classical-VS-Other |
1.228210E-01 |
| Classical-VS-Normal |
1.408140E-04 |
| Tall-VS-Follicular |
1.370240E-02 |
| Tall-VS-Other |
1.161370E-01 |
| Tall-VS-Normal |
4.525600E-02 |
| Follicular-VS-Other |
7.167800E-01 |
| Follicular-VS-Normal |
1.82649999569406E-08 |
| Other-VS-Normal |
1.042920E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.24539999821505E-08 |
| Normal-vs-N1 |
1.562140E-04 |
| N0-vs-N1 |
9.963400E-01 |
|
|
